Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia

Zaragoza 50009

0 studies enrolling now · 3 studies all time

What they study most

HER2+ Metastatic Breast Cancer (MBC), Non-Small Cell Lung Cancer, Triple Negative Breast Cancer

Studies at this site

• A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer — Stopped early
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed
• A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Completed